MDR Charting, page-266

I think there will be an announcement late December to update the MOU as binding, an official update to confirm 1M subscribers and something else that is forward looking. If we're lucky perhaps an agreement with an entity(s) to take the entire share block.

As part of this strategic deal, MedAdvisor also is announcing the execution of an MOU with EBOS Institutional Healthcare’s HPS and Zest businesses that relates to the provision of services over a 3 year term. The parties will work towards executing binding agreements by 31 December 2017.

At today's price 88M is just over $4M. They will see a dramatic decrease in return if they sell on market. Just because December 1 the shares are released from escrow doesn't mean they will commence selling. Management have steered the ship and developed a monopoly product, they have been good to shareholders so far, I don't see them turning their backs and making meagre profits at the expense of the share price, EBOS and retail holders.